Abstract:Background: Glycosylated hemoglobin (HbA1c) is recommended for diagnosing and monitoring type 2 diabetes. However, the monitoring frequency in real-world applications has not yet reached the recommended frequency in the guidelines. Developing machine learning models to screen patients with poor glycemic control in patients with T2D could optimize management and decrease medical service costs. Methods: This study was carried out on patients with T2D who were examined for HbA1c at the Sichuan Provincial People's Hospital from April 2018 to December 2019. Characteristics were extracted from interviews and electronic medical records. The data (excluded FBG or included FBG) were randomly divided into a training dataset and a test dataset with a radio of 8:2 after data pre-processing. Four imputing methods, four screening methods, and six machine learning algorithms were used to optimize data and develop models. Models were compared on the basis of predictive performance metrics, especially on the model benefit (MB, a confusion matrix combined with economic burden associated with therapeutic inertia). The contributions of features were interpreted using SHapley Additive exPlanation (SHAP). Finally, we validated the sample size on the best model. Results: The study included 980 patients with T2D, of whom 513 (52.3%) were defined as positive (need to perform the HbA1c test). The results indicated that the model trained in the data (included FBG) presented better forecast performance than the models that excluded the FBG value. The best model used modified random forest as the imputation method, ElasticNet as the feature screening method, and the LightGBM algorithms and had the best performance. The MB, AUC, and AUPRC of the best model, among a total of 192 trained models, were 43475.750 (¥), 0.972, 0.944, and 0.974, respectively. The FBG values, previous HbA1c values, having a rational and reasonable diet, health status scores, type of manufacturers of metformin, interval of measurement, EQ-5D scores, occupational status, and age were the most significant contributors to the prediction model. Conclusion: We found that MB could be an indicator to evaluate the model prediction performance. The proposed model performed well in identifying patients with T2D who need to undergo the HbA1c test and could help improve individualized T2D management.

Mathematical model for assessing glycemic control in type 2 diabetes mellitus

Glycated Hemoglobin (HbA1c): Clinical Applications of a Mathematical Concept

Utility of Glycated Hemoglobin in Diagnosing Type 2 Diabetes Mellitus: A Community-Based Study

Prediction of glycosylated hemoglobin level in patients with cardiovascular diseases and type 2 diabetes mellitus with respect to anti-diabetic medication

Development and economic assessment of machine learning models to predict glycosylated hemoglobin in type 2 diabetes

The association between self-monitoring of blood glucose and HbA1c in type 2 diabetes

A Kinetic Model for Glucose Levels and Hemoglobin A1c Provides a Novel Tool for Individualized Diabetes Management

The Usefulness of Glycated Hemoglobin (HbA1c) in the Detection of Diabetes Mellitus

An economic value of the glycated hemoglobin test in diabetes mellitus type 2 diagnosis

Glycated Albumin Level and Its Influential Factors in Type 2 Diabetes Mellitus

Defining the Relationship Between Glycated Albumin and HBA1c in Individuals with a Diverse Spectrum of Glucose Metabolism

Primary Assessment of Enzymatic Measurement of Glycated Albumin

Clinical Utility of Glycated Albumin in Type 2 Diabetic Patients

Prevalence of poor glycemic control and the monitoring utility of glycated albumin among diabetic patients attending clinic in tertiary hospitals in Dodoma, Tanzania: A cross-sectional study protocol

[Relationship Between Glycated Albumin Level and Pancreatic Β Cell Function in Newly Diagnosed Type 2 Diabetics].

Glycated Albumin is Superior to Hemoglobin A1c for Evaluating the Presence and Severity of Coronary Artery Disease in Type 2 Diabetic Patients.

Assessment of enzymatic method for glycated albumin and its correlation research with the diagnosis of diabetes mellitus

Implications of glycemic risk index across different levels of glycated hemoglobin (HbA1c) in type 1 diabetes

[Combined utility of hemoglobin A1c and glycated albumin in diabetic screening].

Glycated albumin is superior to glycated hemoglobin for glycemic control assessment at an early stage of diabetes treatment: A multicenter, prospective study

Significance of glycosylated hemoglobin A1c and glycated albumin for the diagnosis of gestational diabetes mellitus